MicroRNA 6820 (MIR6820)

MicroRNA 6820 (MIR6820) is a predicted human microRNA gene encoding a non-coding RNA molecule approximately 20–24 nucleotides in length. Like other microRNAs, MIR6820 likely participates in post-transcriptional regulation of gene expression by binding to complementary sequences on target mRNAs, resulting in their degradation or translational repression. The mature form is produced from a primary transcript by sequential cleavage via the Drosha and Dicer ribonucleases and is loaded into the RNA-induced silencing complex (RISC) for activity. However, as of the current evidence, MIR6820 lacks specific functional annotation, target genes, disease associations, or therapeutic relevance. It is not considered an established therapeutic target, and currently there is no literature describing clinical, functional, or biomarker significance for this specific microRNA[1]. Notes on correctness: - The entry is not clearly established as a therapeutic target and very little is known about its function or relevance in disease and drug response. - The name and identifiers match standard nomenclature, but no functional data or clinical significance is available[1]. - If detailed mechanistic or disease involvement is required, this target is currently too poorly characterized for that purpose.

Other names

hsa-mir-6820microRNA mir-6820MIR6820

Not applicable (for this specific microRNA); general miRNA mechanism involves binding to target mRNAs to mediate degradation or inhibition of translation[1][3][5].